Tilray | Umsatzkosten



Cost Of Sales Veränderung Datum
Alaunos Therapeutics 0 18K 2024-09
Aurora Cannabis CAD 78.85M 891K 2024-12
Avita Medical AUD 2.28M 170K 2024-12
Canopy Growth CAD 50.66M 9.51M 2024-12
Cronos Group USD 19.65M 1.12M 2025-06
Divis Laboratories Ltd 10.68B 870M 2025-06
Ionis Pharmaceuticals USD 4.15M 3.15M 2025-06
IQVIA Holdings USD 2.97B 439M 2025-06
Knight Therapeutics CAD 47.25M 990K 2024-09
Moderna USD 119M 29M 2025-06
Organigram Holdings CAD 41.68M 69.31M 2024-12
Organon & Co USD 720M 48M 2025-06
Revvity USD 327.73M 38.51M 2025-06
Tilray USD 149.73M 9.39M 2024-11
Viatris USD 2.25B 229.7M 2025-06
Xeris Pharmaceuticals USD 9.48M 4.12M 2024-12


Tilray Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.